Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Biliary Malignant Tumors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT02284802
What this trial is testing

Early Detection of Tumors of the Digestive Tract by Confocal Endomicroscopy

Who this might be right for
Barrett EsophagusGastric Antrectomy PartialBiliary Duct Stricture+4 more
Fauze Maluf Filho 87
Early research (Phase 1)Study completedNCT00551096
What this trial is testing

Gemcitabine/Capecitabine/ZD6474 in Advanced Solid Tumors

Who this might be right for
Malignant Solid TumourBiliary CancerPancreatic Cancer
University of Colorado, Denver 23
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07841873
What this trial is testing

Zanidatamab Combined With Liposomal Irinotecan and Capecitabine for Second-line Treatment of HER2-positive Unresectable Biliary Tract Tumors

Who this might be right for
Biliary Tract Cancer
Anhui Provincial Hospital 15
Not applicableUnknownNCT02255669
What this trial is testing

Fully Covered SEMS Versus Partially Covered SEMS With Anti-migration System for Malignant Distal Biliary Obstruction

Who this might be right for
Biliary Tract Neoplasms
Samsung Medical Center 106
Not applicableStudy completedNCT04801719
What this trial is testing

Endoluminal Radiofrequency Ablation for the Treatment of Malignant Biliary Stenosis

Who this might be right for
Radiofrequency AblationBiliary Tract CancerStent Complication+1 more
Brno University Hospital 76
Early research (Phase 1)Looking for participantsNCT07197554
What this trial is testing

A Phase 1/1B Study of ST-01156, a Small Molecule RBM39 Degrader, in Patients With Advanced Solid Malignancies

Who this might be right for
Advanced Solid TumorsEwing SarcomaHepatocellular Carcinoma (HCC)+1 more
SEED Therapeutics, Inc. 171
Early research (Phase 1)Study completedNCT00003867
What this trial is testing

Irinotecan and Capecitabine in Treating Patients With Solid Tumors

Who this might be right for
Cancer
Montefiore Medical Center 30
Large-scale testing (Phase 3)Study completedNCT00262769
What this trial is testing

Gemcitabine With or Without Cisplatin in Treating Patients With Unresectable Locally Advanced or Metastatic Cholangiocarcinoma or Other Biliary Tract Tumors

Who this might be right for
Extrahepatic Bile Duct CancerGallbladder Cancer
University College, London 324
Early research (Phase 1)Ended earlyNCT04209465
What this trial is testing

BDTX-189, an Orally Available Allosteric ErbB Inhibitor, in Patients With Advanced Solid Tumors.

Who this might be right for
Solid Tumor
Black Diamond Therapeutics, Inc. 91
Testing effectiveness (Phase 2)Study completedNCT00096083
What this trial is testing

Hepatic Arterial Infusion of Melphalan With Hepatic Perfusion in Treating Patients With Unresectable Liver Cancer

Who this might be right for
Cancer
Delcath Systems Inc. 56
Early research (Phase 1)Looking for participantsNCT04900818
What this trial is testing

Study of TJ033721 (Givastomig) in Subjects With Advanced or Metastatic Solid Tumors

Who this might be right for
Solid TumorAdvanced CancerMetastatic Cancer+5 more
I-Mab Biopharma US Limited 330
Testing effectiveness (Phase 2)Ended earlyNCT06024174
What this trial is testing

BMS-986466 With Adagrasib With or Without Cetuximab in Participants With Kirsten Rat Sarcoma Virus Glycine 12 to Cysteine (KRAS G12C)-Mutant Solid Tumors

Who this might be right for
Advanced Solid Tumors
Bristol-Myers Squibb 5
Not applicableEnrolling By InvitationNCT05745233
What this trial is testing

Intraperitoneal Immune Checkpoint Inhibitor for Malignant Ascites

Who this might be right for
Malignant Ascites
China Medical University Hospital 30
Post-approval studies (Phase 4)Study completedNCT00980889
What this trial is testing

RCT Steel (Wallstent®) vs Nitinol (Wallflex®) Bile Duct Stent for Palliation of Malignant Obstruction

Who this might be right for
Biliary Tract NeoplasmsPancreatic NeoplasmsStent Occlusion
Stockholm South General Hospital 400
Early research (Phase 1)Study completedNCT01927965
What this trial is testing

Study of Minnelide™ in Patients With Advanced GI Tumors

Who this might be right for
Advanced Gastrointestinal Tumors
Minneamrita Therapeutics LLC 45
Not applicableStudy completedNCT02649712
What this trial is testing

Unilateral Stenting Versus Bilateral Stenting for Malignant Hilar Biliary Obstruction

Who this might be right for
CholangiocarcinomaGallbladder CarcinomaHepatocellular Carcinoma
Xuzhou Central Hospital 72
Not applicableStudy completedNCT03729882
What this trial is testing

Primary EUS-GBD in Patients With Unresectable Malignant Biliary Obstruction and Cystic Duct Orifice Involvement.

Who this might be right for
Acute Cholecystitis
Instituto Ecuatoriano de Enfermedades Digestivas 22
Testing effectiveness (Phase 2)Active Not RecruitingNCT04579380
What this trial is testing

Basket Study of Tucatinib and Trastuzumab in Solid Tumors With HER2 Alterations

Who this might be right for
Uterine NeoplasmsUterine Cervical NeoplasmsBiliary Tract Neoplasms+3 more
Seagen, a wholly owned subsidiary of Pfizer 217
Not applicableWithdrawnNCT03353181
What this trial is testing

Application of Endoscopic Scissors Cutting ENBD Tube in the Treatment of Malignant Hilar Biliary Strictures

Who this might be right for
Endoscopic Retrograde CholangiopancreatographyKlatskin Tumor
Changhai Hospital
Not applicableStudy completedNCT00900302
What this trial is testing

OX-40 Protein Expression in the Sentinel Lymph Nodes of Patients With Cancer

Who this might be right for
Cancer
OHSU Knight Cancer Institute 98
Next Page